-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Opening Remarks

Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
Program: Scientific Workshops
Session: Opening Remarks
Friday, December 6, 2024, 2:00 PM-2:05 PM

Stephanie Valerie Seremetis, MD

Novo Nordisk, Plainsboro, NC

Disclosures: Seremetis: Novo Nordisk: Current Employment, Current equity holder in publicly-traded company; TEVA: Current equity holder in publicly-traded company.

<< Previous Presentation | Next Presentation